These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 10342946

  • 1. No value of oral clodronic acid in malignant osteolysis.
    Prescrire Int; 1998 Aug; 7(36):104. PubMed ID: 10342946
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases].
    Tubiana-Hulin M, Beuzeboc P, Mauriac L, Barbet N, Frenay M, Monnier A, Pion JM, Switsers O, Misset JL, Assadourian S, Bessa E.
    Bull Cancer; 2001 Jul; 88(7):701-7. PubMed ID: 11495824
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intravenous pamidronic acid: new indications. Useful palliative treatment for osteolysis.
    Prescrire Int; 1998 Aug; 7(36):103-5. PubMed ID: 10342945
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clodronate in the management of bone metastases: a clinical study of 91 patients.
    Serkies K, Jereczek-Fossa B, Badzio A, Jassem J.
    Neoplasma; 1999 Aug; 46(5):317-22. PubMed ID: 10665850
    [Abstract] [Full Text] [Related]

  • 8. Use of bisphosphonates can dramatically improve pain in advanced hormone-refractory prostate cancer patients.
    Rodrigues P, Hering F, Campagnari JC.
    Prostate Cancer Prostatic Dis; 2004 Aug; 7(4):350-4. PubMed ID: 15534620
    [Abstract] [Full Text] [Related]

  • 9. [Double-blind trial of oral clodronate in breast cancer patients with bone metastases].
    Paterson AH, Powles TJ, Kanis JA, McCloskey E, Hanson J, Ashley S.
    Bull Cancer; 1993 Aug; 80(10 Suppl):50-6. PubMed ID: 8081032
    [No Abstract] [Full Text] [Related]

  • 10. [An experience with combined therapy of radiation and Bonephos for osteolytic metastases of breast cancer].
    Poliakov PIu, Larionova NA, Bychenkov OA, Moc'kin VG.
    Vopr Onkol; 1999 Aug; 45(3):311-3. PubMed ID: 10443239
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of hormone-refractive prostatic carcinoma with painful bone metastasis. Epirubicin vs. clodronate vs. epirubicin plus clodronate].
    Heidenreich A.
    Urologe A; 1997 Nov; 36(6):568. PubMed ID: 9487597
    [No Abstract] [Full Text] [Related]

  • 12. The analgesic efficacy of clodronate compared with placebo in patients with painful bone metastases from prostatic cancer.
    Strang P, Nilsson S, Brändstedt S, Sehlin J, Borghede G, Varenhorst E, Bandman U, Borck L, Englund G, Selin L.
    Anticancer Res; 1997 Nov; 17(6D):4717-21. PubMed ID: 9494595
    [Abstract] [Full Text] [Related]

  • 13. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
    Clemons MJ, Dranitsaris G, Ooi WS, Yogendran G, Sukovic T, Wong BY, Verma S, Pritchard KI, Trudeau M, Cole DE.
    J Clin Oncol; 2006 Oct 20; 24(30):4895-900. PubMed ID: 17001071
    [Abstract] [Full Text] [Related]

  • 14. [Randomized trial of two administration schedule of bonephos (Clodronate) in patients with painful bone metastasis].
    Moiseenko VM, Blinov NN, Semiglazov VV, Konstantinova MM, Trishkina EA.
    Vopr Onkol; 1998 Oct 20; 44(6):725-8. PubMed ID: 10087976
    [Abstract] [Full Text] [Related]

  • 15. [Dichloromethylene diphosphonate (Cl2MDP) treatment of hypercalcaemia produced from bone metastases (author's transl)].
    Delmas P, Chapuy MC, Vignon E, Briançon D, Charhon S, Meunier PJ.
    Nouv Presse Med; 1982 Apr 24; 11(19):1471-4. PubMed ID: 6210878
    [Abstract] [Full Text] [Related]

  • 16. The use of bisphosphonates in palliative treatment of bone metastases in a terminally ill, oncological elderly population.
    Santangelo A, Testai M, Barbagallo P, Manuele S, Di Stefano A, Tomarchio M, Trizzino G, Musumeci G, Panebianco P, Maugeri D.
    Arch Gerontol Geriatr; 2006 Apr 24; 43(2):187-92. PubMed ID: 16325938
    [Abstract] [Full Text] [Related]

  • 17. [Use of clodronic acid in mineral metabolism conditions: state of the art in 2000].
    Brandi ML.
    Minerva Med; 2001 Aug 24; 92(4):251-68. PubMed ID: 11535969
    [Abstract] [Full Text] [Related]

  • 18. Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain.
    Ernst DS, Tannock IF, Winquist EW, Venner PM, Reyno L, Moore MJ, Chi K, Ding K, Elliott C, Parulekar W.
    J Clin Oncol; 2003 Sep 01; 21(17):3335-42. PubMed ID: 12947070
    [Abstract] [Full Text] [Related]

  • 19. Reduction of visible bone metastases by clodronate therapy in breast cancer.
    Tjalma WA, Buytaert PM, Berneman ZN.
    Eur J Gynaecol Oncol; 2001 Sep 01; 22(3):215-6. PubMed ID: 11501775
    [Abstract] [Full Text] [Related]

  • 20. Clodronate prevents prosthetic migration: a randomized radiostereometric study of 50 total knee patients.
    Hilding M, Ryd L, Toksvig-Larsen S, Aspenberg P.
    Acta Orthop Scand; 2000 Dec 01; 71(6):553-7. PubMed ID: 11145380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.